AAAAAA
Results: 1-25/27
Authors:
KERN W
BRAESS J
BERTZ H
POTT C
SCHLEYER E
FINKE J
RUCHEL R
HIDDEMANN W
Citation: W. Kern et al., CHRONIC SYSTEMIC ASPERGILLOSIS IN A PATIENT WITH ACUTE MYELOID-LEUKEMIA, Annals of hematology, 76(3-4), 1998, pp. 175-177
Authors:
BRAESS J
FREUND M
HANAUSKE A
HEIL G
KAUFMANN C
KERN W
SCHUSSLER M
HIDDEMANN W
SCHLEYER E
Citation: J. Braess et al., ORAL CYTARABINE OCFOSFATE IN ACUTE MYELOID-LEUKEMIA AND NON-HODGKINS-LYMPHOMA - PHASE I II STUDIES AND PHARMACOKINETICS/, Leukemia, 12(10), 1998, pp. 1618-1626
Authors:
LEGLER TJ
FISCHER I
DITTMANN J
SIMSON G
LYNEN R
HUMPE A
RIGGERT J
SCHLEYER E
KERN W
HIDDEMANN W
KOHLER M
Citation: Tj. Legler et al., FREQUENCY AND CAUSES OF REFRACTORINESS IN MULTIPLY TRANSFUSED PATIENTS, Annals of hematology, 74(4), 1997, pp. 185-189
Authors:
SCHLEYER E
KUHN H
UNTERHALT M
KAUFMANN CC
KERN W
BRAESS J
STRAUBEL G
HIDDEMANN W
Citation: E. Schleyer et al., ORAL IDARUBICIN PHARMACOKINETICS - CORRELATION OF TROUGH LEVEL WITH IDARUBICIN AREA UNDER CURVE, Leukemia, 11, 1997, pp. 15-21
Authors:
REUTER C
SCHLEYER E
ROLF C
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: C. Reuter et al., DIFFERENTIAL EFFECT OF GM-CSF PRETREATMENT ON INTRACELLULAR ARA-C METABOLISM IN NORMAL BONE-MARROW MONONUCLEAR-CELLS VS ACUTE MYELOID-LEUKEMIA (AML) BLASTS, Leukemia, 11(4), 1997, pp. 561-571
Authors:
BERKOVIC D
FLEER EAM
BREASS J
PFORTNER J
SCHLEYER E
HIDDEMANN W
Citation: D. Berkovic et al., THE INFLUENCE OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE ON THE METABOLISM OF PHOSPHATIDYLCHOLINE IN HUMAN LEUKEMIC HL-60 AND RAJI CELLS, Leukemia, 11(12), 1997, pp. 2079-2086
Authors:
KERN W
SCHLEYER E
UNTERHALT M
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: W. Kern et al., HIGH ANTILEUKEMIC ACTIVITY OF SEQUENTIAL HIGH-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE IN PATIENTS WITH REFRACTORY ACUTE LEUKEMIAS - RESULTS OF A CLINICAL-PHASE-II STUDY, Cancer, 79(1), 1997, pp. 59-68
Authors:
JAHNSSTREUBEL G
REUTER C
LANDWEHR UAD
UNTERHALT M
SCHLEYER E
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: G. Jahnsstreubel et al., ACTIVITY OF THYMIDINE KINASE AND OF POLYMERASE-ALPHA AS WELL AS ACTIVITY AND GENE-EXPRESSION OF DEOXYCYTIDINE DEAMINASE IN LEUKEMIC BLASTS ARE CORRELATED WITH CLINICAL-RESPONSE IN THE SETTING OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-BASED PRIMING BEFORE AND DURING TAD-9 INDUCTION THERAPY IN ACUTE MYELOID-LEUKEMIA, Blood, 90(5), 1997, pp. 1968-1976
Authors:
KERN W
SCHLEYER E
BRAESS J
OHNESORGE J
UNTERHALT M
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: W. Kern et al., FLUDARABINE, INTERMITTENT-SEQUENTIAL HIGH-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE (FIS-HAM) THERAPY IN ADVANCED ACUTE LEUKEMIAS, Blood, 90(10), 1997, pp. 3831-3831
Authors:
BRAESS J
FREUND M
HANAUSKE A
SCHUSSLER M
HIDDEMANN W
KERN W
UNTERHALT M
SCHLEYER E
Citation: J. Braess et al., PHASE-I STUDY OF ORAL CYTARABINE-OCPHOSPHATE (YNK01) IN AML AND NHL -PHARMACOKINETICS AND CLINICAL-RESULTS, Blood, 90(10), 1997, pp. 1473-1473
Authors:
BRAESS J
PFORTNER J
KAUFMANN CC
RAMSAUER B
UNTERHALT M
HIDDEMANN W
SCHLEYER E
Citation: J. Braess et al., DETECTION AND DETERMINATION OF THE MAJOR METABOLITES OF [H-3] CYTOSINE-ARABINOSIDE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 676(1), 1996, pp. 131-140
Authors:
BRAESS J
KERN W
UNTERHALT M
KAUFMANN CC
RAMSAUER B
SCHUSSLER M
KAESERFROHLICH A
HIDDEMANN W
SCHLEYER E
Citation: J. Braess et al., RESPONSE TO CYTARABINE OCFOSFATE (YNKO1) IN A PATIENT WITH CHRONIC LYMPHOCYTIC-LEUKEMIA REFRACTORY TO TREATMENT WITH CHLORAMBUCIL PREDNISONE, FLUDARABINE, AND PREDNIMUSTINE/MITOXANTRONE/, Annals of hematology, 73(4), 1996, pp. 201-204
Authors:
SCHLEYER E
KUHN S
RUHRS H
UNTERHALT M
KAUFMANN CC
KERN W
BRAESS J
STRAUBEL G
HIDDEMANN W
Citation: E. Schleyer et al., ORAL IDARUBICIN PHARMACOKINETICS - CORRELATION OF TROUGH LEVEL WITH IDARUBICIN AREA UNDER CURVE, Leukemia, 10(4), 1996, pp. 707-712
Authors:
HIDDEMANN W
SCHLEYER E
UNTERHALT M
KERN W
BUCHNER T
Citation: W. Hiddemann et al., OPTIMIZING THERAPY FOR ACUTE MYELOID-LEUKEMIA BASED ON DIFFERENCES ININTRACELLULAR METABOLISM OF CYTOSINE-ARABINOSIDE BETWEEN LEUKEMIC BLASTS AND NORMAL MONONUCLEAR BLOOD-CELLS, Therapeutic drug monitoring, 18(4), 1996, pp. 341-349
Authors:
SCHLEYER E
REINHARDT J
UNTERHALT M
HIDDEMANN W
Citation: E. Schleyer et al., HIGHLY SENSITIVE COUPLED-COLUMN HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE SEPARATION AND QUANTITATION OF THE DIASTEREOMERS OF LEUCOVORIN AND 5-METHYLTETRAHYDROFOLATE IN SERUM AND URINE, Journal of chromatography B. Biomedical applications, 669(2), 1995, pp. 319-330
Authors:
RAMSAUER B
BRAESS J
UNTERHALT M
KAUFMANN CC
HIDDEMANN W
SCHLEYER E
Citation: B. Ramsauer et al., HIGHLY SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR 1-BETA-D-ARABINOFURANOSYLCYTOSINE-5'-STEARYL PHOSPHATE (CYTARABINE-OCFOSFATE), Journal of chromatography B. Biomedical applications, 665(1), 1995, pp. 183-192
Authors:
SCHLEYER E
BRAESS J
RAMSAUER B
UNTERHALT M
KAUFMANN C
WILDE S
SCHUSSLER M
HIDDEMANN W
Citation: E. Schleyer et al., PHARMACOKINETICS OF ARA-CMP-STEARATE (YNK01) - PHASE-I STUDY OF THE ORAL ARA-C DERIVATIVE, Leukemia, 9(6), 1995, pp. 1085-1090
Authors:
JAHNSSTREUBEL G
REUTER C
UNTERHALT M
SCHLEYER E
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: G. Jahnsstreubel et al., BLAST CELL PROLIFERATIVE ACTIVITY AND SENSITIVITY TO CM-CSF IN-VITRO ARE ASSOCIATED WITH EARLY RESPONSE TO TAD-9 INDUCTION THERAPY IN ACUTEMYELOID-LEUKEMIA, Leukemia, 9(11), 1995, pp. 1857-1863
Authors:
SCHLEYER E
KAMISCHKE A
KAUFMANN CC
UNTERHALT M
HIDDEMANN W
Citation: E. Schleyer et al., NEW ASPECTS ON THE PHARMACOKINETICS OF MITOXANTRONE AND ITS 2 MAJOR METABOLITES, Leukemia, 8(3), 1994, pp. 435-440
Authors:
REUTER C
DERLANDWEHR UA
SCHLEYER E
ZUHLSDORF M
AMELING C
ROLF C
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: C. Reuter et al., MODULATION OF INTRACELLULAR METABOLISM OF CYTOSINE-ARABINOSIDE IN ACUTE MYELOID-LEUKEMIA BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Leukemia, 8(2), 1994, pp. 217-225
Authors:
REUTER C
ROLF C
SCHLEYER E
WOERMANN B
BUECHNER T
HIDDEMANN W
Citation: C. Reuter et al., DIFFERENTIAL EFFECT OF GM-CSF PRIMING ON INTRACELLULAR ARA-C METABOLISM IN NORMAL MONONUCLEAR BONE-MARROW CELLS VERSUS AML BLASTS, Experimental hematology, 22(8), 1994, pp. 764-764
Authors:
JAHNSSTREUBEL G
REUTER C
UNTERHALT M
SCHLEYER E
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: G. Jahnsstreubel et al., CORRELATION OF BLAST CELL PROLIFERATIVE ACTIVITY AND SENSITIVITY TO GM-CSF WITH CLINICAL-RESPONSE TO TAD9 INDUCTION THERAPY IN ACUTE MYELOID, Experimental hematology, 22(8), 1994, pp. 772-772
Authors:
HIDDEMANN W
WORMANN B
REUTER C
SCHLEYER E
ZUHLSDORF M
BOCKMANN A
BUCHNER T
Citation: W. Hiddemann et al., NEW PERSPECTIVES IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA BY HEMATOPOIETIC GROWTH-FACTORS, Seminars in oncology, 21(6), 1994, pp. 33-38
Authors:
HEUSSNER P
WILLEMZE R
GANSER A
HANAUSKE A
AMADORI S
HEIL G
SCHLEYER E
HIDDEMANN W
SELBACH J
SCHUSSLER M
FREUND M
Citation: P. Heussner et al., YNK01, AN ORAL ARA-C DERIVATIVE IN PATIENTS WITH AML, MDS, LOW-GRADE MALIGNANT NHL AND CML, Blood, 84(10), 1994, pp. 10000302-10000302
Authors:
SCHLEYER E
LOHMANN R
ROLF C
GRALOW A
KAUFMANN CC
UNTERHALT M
HIDDEMANN W
Citation: E. Schleyer et al., COLUMN-SWITCHING SOLID-PHASE TRACE-ENRICHMENT HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR MEASUREMENT OF BUPRENORPHINE AND NORBUPRENORPHINE IN HUMAN PLASMA AND URINE BY ELECTROCHEMICAL DETECTION, Journal of chromatography. Biomedical applications, 614(2), 1993, pp. 275-283